Neuropeptide Y: immunocytochemical localization to and effect upon feline pial arteries and veins in vitro and in situ.
Plexuses of nerve fibres containing neuropeptide Y (NPY)-like immunoreactivity invest pial arteries belonging to the circle of Willis, pial arterioles, occasionally penetrating arterioles and large veins. A more sparse supply of NPY-like fibres were observed around pial veins and venules. The NPY-immunoreactive fibres are located within the adventitia or at the adventitia-media border. Only occasional fibres are present in cerebral vessels of animals in which the superior cervical ganglion has been removed one week previously. Administration of NPY resulted in strong, concentration-dependent contractions of isolated feline middle cerebral arteries whereas administration of avian pancreatic polypeptide (APP) elicited weak contractions. In chloraloseanaesthetized cats, perivascular microapplication of NPY in situ resulted in marked concentration-dependent contractions of cerebral pial arterioles (34.7 +/- 6.6%; maximum decrease in calibre with NPY. Perivascular administration of NPY resulted in the constriction of pial veins but the magnitude of the venous calibre reductions was smaller than the response of arterioles at each reductions was smaller than the response of arterioles at each concentration examined. APP did not elicit contraction of pial arterioles or veins during in situ conditions. The pharmacological and immunocytochemical results strongly indicate the existence of a novel perivascular neuronal system containing NPY, which mediates contraction of cerebral blood vessels and NPY is colocalized with NA in sympathetic nerves.
D000818:Animals; D001160:Arterioles / Q000294:innervation / Q000378:metabolism; D002415:Cats; D002536:Cerebral Arteries / Q000294:innervation / Q000378:metabolism*; D005260:Female; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000378:metabolism; D009412:Nerve Fibers / Q000378:metabolism; D009419:Nerve Tissue Proteins / Q000378:metabolism* / Q000494:pharmacology; D009478:Neuropeptide Y; D010191:Pancreatic Polypeptide / Q000494:pharmacology; D010841:Pia Mater / Q000098:blood supply*; D014655:Vascular Resistance / Q000187:drug effects*; D014661:Vasoconstriction / Q000187:drug effects*
D009419:Nerve Tissue Proteins; D009478:Neuropeptide Y; D010191:Pancreatic Polypeptide